Intended for healthcare professionals

Letters Quetiapine and major depressive disorder

Severe adverse reactions associated with quetiapine

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1575 (Published 24 March 2015) Cite this as: BMJ 2015;350:h1575
  1. Detlef Degner, senior consultant1
  1. 1Department of Psychiatry and Psychotherapy, University of Göttingen, D-37075 Göttingen, Germany
  1. ddegner{at}gwdg.de

Over the past 20 years the use of second generation antipsychotics has shifted from schizophrenia to affective disorders. Pringsheim and colleagues described the benefits and risks of quetiapine as adjunctive treatment in major depressive disorder.1 However, they did not mention some …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription